Tergus Hires Quality Assurance (QA) Executive – Kelly Thomas has 18 years of experience in quality control and cGMP
We have some great news to share: Tergus (www.terguspharma.com), the industry leader in topical pharmaceutical development, skin biology & IVRT testing and Phase I – III cGMP clinical supply manufacturing, has hired Ms. Kelly Thomas to head the company’s Quality Assurance (QA) and Compliance departments….
Skin Cancer Drug Fast-tracked to Patients in UK
An interesting article just appeared on the BBC news about a skin cancer drug that has been fast-tracked through Early Access to Medicines scheme (EAMS), launched in England last April. The government program is designed to get potentially life-saving treatments to patients faster. The report…
BioPharma Reporter Analysis of Biosimilars
There was an interesting article in BioPharma Reporter on the barriers to the biosimilar market in the U.S. What stood out for us in the article is the discussion from GlobalData analyst Lakshmi Dharmajan on alternative delivery systems enabling manufacturers of biosimilars to gain patient…
Recent Studies on Oxytocin as a Therapy for Autism
Researchers at Emery University have just published a study in Neuropsychopharmacology on the use of Oxytocin as a therapy to enhance social function in psychiatric disorders, including autism spectrum disorders and schizophrenia. The full article can be found here: http://bit.ly/1G1VWm3. Tergus worked with researchers at the…
Winning Tech Transfer Strategies Featured Topic at Outsourced Pharma West
Outsourced Pharma West, August 25-26, 2015 at the Hyatt Regency in La Jolla, California, is delivering on its promise to be an elite conference for executives who manage outsourced relationships. The agenda was created based on industry feedback and is designed to deliver the most…
Tergus at the 6th AGAH Dermatology Product Development Workshop
The 6th AGAH Dermatology Product Development Workshop has successfully wrapped its first day. The first session in the workshop was given by Tergus CEO and co-founder, Vijendra Nalamothu, PhD. Dr. Nalamothu’s session focused on discussing the Quality by Design (QbD) approach for topical formulation development….
The View from the Floor of the World Congress of Dermatology Conference
The World Congress of Dermatology (www.derm2015.org) has convened in Vancouver and the sessions and exhibits are keeping Tergus CEO Vijendra Nalamothu busy. His posts from the floor have revealed some interesting trends. “Skin to Live in.” The theme of having skin that patients can live…
Tergus Hires Michele Nathan Borek
The following release just went over the newswire. We are very pleased the Michele Nathan Borek has joined Tergus! Tergus Hires Leading Sales and Marketing ExecutiveMichele Nathan Borek has more than 20 years of experience in creating growth for life science companies Research Triangle Park,…
Dawn Slann joined Tergus effective June 11, 2018 in the capacity of Senior Director, Quality Assurance.
Dawn brings 33 years of extensive experience in Quality, Regulatory and Compliance in the pharmaceutical industry. In her role as Senior Director, Quality Assurance, Dawn will Dawn brings 33 years of extensive experience in Quality, Regulatory and Compliance in the pharmaceutical industry. In her role…
- Large vs. Small – Why small, agile manufacturing operations trump large companies
- SUPAC-SS GUIDANCE EXPLAINED – When In Vitro Release Testing (IVRT) is Required for Semisolid Products
- Continuous Manufacturing and Semi-Solids
- Tergus Hires Quality Assurance (QA) Executive – Kelly Thomas has 18 years of experience in quality control and cGMP
- Skin Cancer Drug Fast-tracked to Patients in UK